Cardiovascular complications in children with HIV infection

Amy Sims1, Colleen Hadigan

  • 1Pediatric Cardiology, Children's National Medical Center, Washington, DC 20010, USA. asims@cnmc.org

Insights

Cardiovascular complications in children with HIV have shifted from acute to chronic issues due to effective treatment. Research now focuses on understanding and mitigating long-term cardiac risks in these children.

Area of Science:

  • Pediatric Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Cardiovascular complications were a primary cause of death in children with human immunodeficiency virus (HIV) before effective antiretroviral treatment (ART).
  • With ART as standard care, the focus has shifted from acute cardiac events to understanding cardiovascular issues as a chronic manifestation of HIV and its management.
  • This highlights the evolving landscape of pediatric HIV care and its long-term health implications.

Purpose of the Study:

  • To review recent advancements in understanding the impact of HIV and its treatment on cardiovascular health in children.
  • To explore the roles of atherosclerosis, inflammation, biomarkers, and metabolic abnormalities in cardiac function and disease risk.
  • To identify emerging cardiovascular health challenges and strategies for risk reduction in HIV-infected children.

Main Methods:

  • Literature review of recent research on cardiovascular complications in pediatric HIV.
  • Analysis of studies investigating the mechanisms linking HIV, ART, and cardiovascular disease.
  • Synthesis of current knowledge on risk factors and emerging health challenges.

Main Results:

  • HIV and its treatment are associated with chronic cardiovascular changes, including atherosclerosis and inflammation.
  • Biomarkers and metabolic abnormalities play significant roles in cardiac function and cardiovascular disease risk.
  • The full extent of cardiovascular outcomes in HIV-infected children remains under investigation.

Conclusions:

  • Children with HIV face evolving cardiovascular health challenges beyond acute complications.
  • Further research is needed to fully characterize cardiovascular disease risk and implement effective prevention strategies.
  • Proactive cardiovascular risk management is crucial for improving long-term health outcomes in pediatric HIV populations.

Related Concept Videos

Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...